Scarica l'app Stockscreener
3.53
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OM Giù?
Forum
Previsione
Precedente Chiudi:
$3.53
Aprire:
$3.6
Volume 24 ore:
88,581
Relative Volume:
0.12
Capitalizzazione di mercato:
$64.64M
Reddito:
$119.48M
Utile/perdita netta:
$-81.65M
Rapporto P/E:
-0.5187
EPS:
-6.8055
Flusso di cassa netto:
$-47.13M
1 W Prestazione:
+5.37%
1M Prestazione:
+4.75%
6M Prestazione:
-76.00%
1 anno Prestazione:
-69.75%
Intervallo 1D:
$3.42
$3.7399
Intervallo di 1 settimana:
$3.2619
$3.7399
Portata 52W:
$3.00
$21.98
Outset Medical Inc Stock (OM) Company Profile
Nome
Outset Medical Inc
Settore
Industria
Telefono
669-231-8200
Indirizzo
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
3.53 | 64.64M | 119.48M | -81.65M | -47.13M | -6.8055 |
ABT
Abbott Laboratories
|
104.83 | 182.16B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.39B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 112.84B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 48.01B | 6.07B | 1.06B | 1.34B | 1.8063 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Iniziato | BTIG Research | Buy |
| 2024-04-05 | Aggiornamento | CL King | Neutral → Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-17 | Iniziato | CL King | Neutral |
| 2022-11-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-07-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Iniziato | Cowen | Outperform |
| 2021-04-19 | Iniziato | Wells Fargo | Overweight |
| 2020-12-16 | Iniziato | Oppenheimer | Perform |
| 2020-10-12 | Iniziato | Barclays | Overweight |
| 2020-10-12 | Iniziato | BofA Securities | Buy |
| 2020-10-12 | Iniziato | Goldman | Buy |
| 2020-10-12 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Outset Medical Inc Borsa (OM) Ultime notizie
Resistance Check: What is Outset Medical Incs 5 year growth outlookRecession Risk & Daily Technical Forecast Reports - baoquankhu1.vn
If You Invested $1,000 in Outset Medical, Inc. (OM) - Stock Titan
OM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Outset Medical to detail in-house dialysis rollout and nurse impact at AONL2026 - Traders Union
OM SEC FilingsOutset Medical, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical bets on workflow efficiency gains with Tablo Dialysis during AONL2026 - Traders Union
Analyst sentiment on Outset Medical (OM) remains strong following Q4 results - MSN
Short Interest in Outset Medical, Inc. (NASDAQ:OM) Drops By 13.6% - MarketBeat
Momentum Shift: What is Outset Medical Incs 5 year growth outlookQuarterly Profit Summary & Safe Swing Trade Setups - baoquankhu1.vn
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Outset Medical (OM) soars 22.2%: Is further upside left in the stock? - MSN
Outset Medical, Inc. $OM Position Lessened by Pura Vida Investments LLC - MarketBeat
Shorts Report: Is Outset Medical Inc in a bullish channelEarnings Recap Report & Real-Time Volume Surge Alerts - baoquankhu1.vn
Outset Medical (OM) insider amends Form 3 to add option holdings - Stock Titan
OM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FDA Clears Outset Medical’s Next-Generation Hemodialysis System - Medical Product Outsourcing
Outset Medical Earnings Call Highlights Margin Turnaround - TipRanks
Outset Medical webinar spotlights Community Health Systems insourced dialysis expansion - Traders Union
Outset Medical (OM) Gets a Buy from Stifel Nicolaus - The Globe and Mail
Outset Medical, Inc. (OM) Stock Analysis: A Potential 211% Upside Sparks Investor Interest - DirectorsTalk Interviews
Aug Retail: What is Outset Medical Incs 5 year growth outlookPortfolio Return Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect? - MSN
Exit Recap: Can Outset Medical Inc sustain earnings growthForecast Cut & High Yield Stock Recommendations - baoquankhu1.vn
OMOutset Medical, Inc. Latest Stock News & Market Updates - Stock Titan
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results - Yahoo Finance
Leslie Trigg Sells 3,361 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Outset Medical general counsel Brottem sells $9,520 in stock - Investing.com
Outset Medical general counsel Brottem sells $9,520 in stock By Investing.com - Investing.com UK
[Form 4] Outset Medical, Inc. Insider Trading Activity - Stock Titan
Outset Medical, Inc. (NASDAQ:OM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Outset Medical (OM) EVP sells 1,817 shares in RSU tax sell-to-cover - Stock Titan
OM (NASDAQ: OM) Form 144: Proposed sale of 9,319 RSU‑settled shares - Stock Titan
Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion - MSN
Outset Medical, Inc. (NASDAQ:OM) Q4 2025 Earnings Call Transcript - Insider Monkey
US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results - Yahoo Finance
RBC Capital Reaffirms Their Hold Rating on Outset Medical (OM) - The Globe and Mail
Outset Medical (NASDAQ:OM) Given New $15.00 Price Target at BTIG Research - MarketBeat
Outset Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Stifel lowers price target on Outset Medical, Inc. (OM) to $8, maintains buy rating - MSN
BTIG Lowers Price Target for Outset Medical (OM) to $15, Maintai - GuruFocus
Outset Medical stock dips on Q4 EPS miss - MassDevice
What’s the fair value of Outset Medical Inc. stockJuly 2025 Spike Watch & Verified Swing Trading Watchlists - mfd.ru
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strate - GuruFocus
Outset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target - TipRanks
Outset Medical Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth By Investing.com - Investing.com Canada
Outset Medical (OM) Sets 2026 Revenue and Margin Targets - GuruFocus
Outset Medical earnings missed by $0.60, revenue fell short of estimates - Investing.com Canada
OM: Revenue up 5% to $119.5M, margin expands, and next-gen Tablo FDA-cleared for 2026 growth - TradingView
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth - Investing.com
Outset Medical Inc Azioni (OM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):